In parallel, Chen et al. demonstrated that miRNA-30a could decrease the autophagy level to sensitize GIST cells to imatinib mesylate by targeting Beclin-1 (Chen et al., 2020). Here, BECN1 is linked to gastrointestinal stromal tumor.